$25.600
-0.404 (-1.58%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MLYS por análisis de gráficos similares
Alphio's MLYS stock price prediction model matches the current Mineralys Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.42 (-0.71%). The 1-week path is $26.49 (+3.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Mineralys Therapeutics Inc?
Currently, Mineralys Therapeutics Inc (MLYS) is not a strong buy due to its recent performance and financial metrics. The stock is trading at $25.60, down 28.31% year-to-date, indicating significant volatility. The RSI is at 40.695, suggesting it is nearing oversold territory, but still not a clear buy signal. Additionally, the company reported a substantial loss of $241 million in Q2 2026, which raises concerns about its profitability and future cash flow. The main risk is the negative earnings per share (EPS) of -2.85, reflecting ongoing financial struggles despite a positive analyst outlook.
MLYS cerró en $25.60 el Friday, tras bajar -1.58%
Mineralys Therapeutics Inc (MLYS) last closed at $25.6, losing -1.58%. These facts feed the 1-day and 1-week MLYS price prediction above.
Factores de la previsión
Los factores de la previsión de Mineralys Therapeutics Inc (MLYS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MLYS, ordenadas por similitud.
Análisis de estacionalidad de MLYS
Historically the probability of a positive August return for MLYS is 68.25%. September offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MLYS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $11.89 | $12.70 | $12.88 | -50.39% |
| Sep 2026 | $9.91 | $12.70 | $14.73 | -50.39% |
| Oct 2026 | $9.73 | $12.70 | $15.05 | -50.39% |
| Nov 2026 | $13.39 | $16.61 | $19.53 | -35.10% |
| Dec 2026 | $17.09 | $17.18 | $20.56 | -32.88% |
En 2026, se proyecta que Mineralys Therapeutics Inc (MLYS) oscile entre $9.73 y $20.56.
Previsión mensual de Mineralys Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Mineralys Therapeutics Inc promedie $12.70, con un mínimo de $11.89 y un máximo de $12.88.
En Sep de 2026, se proyecta que Mineralys Therapeutics Inc promedie $12.70, con un mínimo de $9.91 y un máximo de $14.73.
En Oct de 2026, se proyecta que Mineralys Therapeutics Inc promedie $12.70, con un mínimo de $9.73 y un máximo de $15.05.
En Nov de 2026, se proyecta que Mineralys Therapeutics Inc promedie $16.61, con un mínimo de $13.39 y un máximo de $19.53.
En Dec de 2026, se proyecta que Mineralys Therapeutics Inc promedie $17.18, con un mínimo de $17.09 y un máximo de $20.56.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.